{"product_id":"spatial-genomics-transcriptomics-market-by-technique-spatial-transcriptomics-spatial-genomics-product-instruments-consumables-software-application-translational-research-drug-discovery-end-user-global-forecast-to-2027","title":"Spatial Genomics \u0026 Transcriptomics Market by Technique (Spatial Transcriptomics, Spatial Genomics), Product (Instruments, Consumables, Software), Application (Translational Research, Drug Discovery), End User, Global Forecast to 2027","description":"\u003cp\u003eSpatial Genomics \u0026amp; Transcriptomics Market by Technique (Spatial Transcriptomics, Spatial Genomics), Product (Instruments, Consumables, Software), Application (Translational Research, Drug Discovery), End User, Global Forecast to 2027\u003c\/p\u003e\n\n\u003cp\u003eThe global spatial genomics and transcriptomics market is projected to reach USD 800 million by 2027 from USD 355 million in 2022, at a CAGR of 17.6% during the forecast period. Market growth is largely driven by the shift from strictly research applications to drug discovery \u0026amp; development for areas such as neurodegenerative diseases and cancer. Spatial genomics and transcriptomics are also anticipated to address current unmet clinical needs in oncology, including the demand for predictive biomarkers of response. These biomarkers assist in developing immunotherapies by offering a greater understanding of the tumor. On the other hand, lack of clarity around outcomes of transcriptomic research, coupled with the high equipment cost, has led to the lower adoption of transcriptomic technologies, thereby limiting the growth of the spatial genomics \u0026amp; transcriptomics market.\u003c\/p\u003e\n\n \u003cp\u003e“By application, the translational research accounted for the largest share of the spatial genomics \u0026amp; transcriptomics market”\u003c\/p\u003e\n\n\u003cp\u003eBased on application, the spatial genomics and transcriptomics market is categorized into translational research and drug discovery \u0026amp; development. The translation research segment dominated the market in 2021, owing to increasing research grants and funding by government and non-government organizations.\u003c\/p\u003e \n\n\u003cp\u003e“Asia Pacific: The fastest-growing region in the spatial genomics \u0026amp; transcriptomics market.”\u003c\/p\u003e\n\n\u003cp\u003eThe Asia Pacific market is projected to grow at the highest CAGR during the forecast period, mainly due to the growing biopharmaceutical industry, increasing R\u0026amp;D spending in Asian countries is one of the major factors driving growth. In addition, Asian economies have modified regulations, policies, and guidelines to promote innovation and commercialization, attracting many domestic industrialists and global market leaders to establish their businesses in this region.\u003c\/p\u003e\n\n\u003cp\u003e“North America: the largest share of the spatial genomics \u0026amp; transcriptomics market”\u003c\/p\u003e\n\n\u003cp\u003eNorth America accounted for the largest share of the spatial genomics \u0026amp; transcriptomics market. Factors such as rising incidence of chronic diseases, increasing research funding for the development of new regenerative medicine, and technological advancements and launch of cell therapies to treat different cancers are the major factors driving the market growth.\u003c\/p\u003e\n\n\u003cp\u003eThe primary interviews conducted for this report can be categorized as follows:\u003c\/p\u003e\n\n\u003cp\u003eBy Respondent: Supply Side- 60% and Demand Side 40%\u003c\/p\u003e\n\n\u003cp\u003eBy Designation: Executives - 40%, Research Scientists- 30%, and Managers - 30%\u003c\/p\u003e\n\n\u003cp\u003eBy Region: North America -51%, Europe -25%, Asia-Pacific -18%, Latin America -3%, Middle East and Africa – 3%\u003c\/p\u003e\n\n\u003cp\u003eMajor Players\u003c\/p\u003e\n\n\u003cp\u003eNanoString Technologies, Inc. (US)\u003c\/p\u003e\n\n\u003cp\u003e10X Genomics (US)\u003c\/p\u003e\n\n\u003cp\u003eIllumina (US)\u003c\/p\u003e\n\n\u003cp\u003eBio-Rad Laboratories (US)\u003c\/p\u003e\n\n\u003cp\u003eBio-Techne Corporation (US)\u003c\/p\u003e\n\n\u003cp\u003eStandard BioTools Inc. (US)\u003c\/p\u003e\n\n\u003cp\u003eGenomic Vision SA (France)\u003c\/p\u003e\n\n\u003cp\u003eAkoya Biosciences, Inc. (US)\u003c\/p\u003e\n\n\u003cp\u003eDanaher Corporation (US)\u003c\/p\u003e\n\n\u003cp\u003eNatera, Inc. (US)\u003c\/p\u003e\n\n\u003cp\u003ePerkinElmer, Inc. (US)\u003c\/p\u003e\n\n\u003cp\u003eSeven Bridges Genomics (US)\u003c\/p\u003e\n\n\u003cp\u003eS2 Genomics, Inc. (US)\u003c\/p\u003e\n\n\u003cp\u003eCantata Bio (US)\u003c\/p\u003e\n\n\u003cp\u003eVizgen Corporation (US)\u003c\/p\u003e\n\n\u003cp\u003eBioSpyder Technologies Inc. (US)\u003c\/p\u003e\n\n\u003cp\u003eOptical Biosystems Inc. (US)\u003c\/p\u003e\n\n\u003cp\u003eMiltenyi Biotec (Germany)\u003c\/p\u003e\n\n\u003cp\u003eUltivue Inc. (US)\u003c\/p\u003e\n\n\u003cp\u003eLunaphore Technologies SA (Switzerland)\u003c\/p\u003e\n\n\u003cp\u003eRebus Biosystems LLC (US)\u003c\/p\u003e\n\n\u003cp\u003eResolve Biosciences (Germany)\u003c\/p\u003e\n\n\u003cp\u003eSingular Genomics, Inc. (US)\u003c\/p\u003e\n\n\u003cp\u003eVeracyte (US)\u003c\/p\u003e\n\n\u003cp\u003eResearch Coverage:\u003c\/p\u003e\n\n\u003cp\u003eThis report provides a detailed picture of the spatial genomics \u0026amp; trancriptomics market. It aims at estimating the size and future growth potential of the market across different segments, such as the product, technology, applications, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.\u003c\/p\u003e \n\n\u003cp\u003eKey Benefits of Buying the Report:\u003c\/p\u003e\n\n\u003cp\u003eThe report will help market leaders\/new entrants by providing them with the closest approximations of the revenue numbers for the overall spatial genomics \u0026amp; transcriptomics market and its segments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, trends, opportunities, and challenges.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"December, 2022 \/ 232 Pages \/ MCW16225599","offer_id":47640078450994,"sku":null,"price":5940.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/spatial-genomics-transcriptomics-market-by-technique-spatial-transcriptomics-spatial-genomics-product-instruments-consumables-software-application-translational-research-drug-discovery-end-user-global-forecast-to-2027","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}